Reuters logo
BRIEF-Madrigal Pharmaceuticals reports Q3 loss per share of $0.68
November 9, 2017 / 1:09 PM / a month ago

BRIEF-Madrigal Pharmaceuticals reports Q3 loss per share of $0.68

Nov 9 (Reuters) - Madrigal Pharmaceuticals Inc

* Madrigal Pharmaceuticals reports 2017 third quarter financial results

* Qtrly loss per share $0.68 ‍​

* ‍As of Sept 30, had cash, cash equivalents and marketable securities of $62.1 million, versus $40.5 million at December 31, 2016​

* On track to report top-line results for nash late this year and hefh early in 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below